Although gamma delta T cell receptor-bearing lymphocytes (gamma delta T cells) constitute a significant minority of circulating and tissue-associated T lymphocytes, the mechanism responsible for the activation of these cells is unknown. To address this question, resting gamma delta TCR+, CD3+, CD4-, CD8-cells isolated from the blood of healthy volunteers were cultured with allogeneic dendritic cells (DC) or monocytes, and their proliferative response measured. DC alone induced gamma delta T cells to proliferate, with a peak response on the sixth day of culture. Pretreatment of DC with an anti-HLA-DR mAb, but not anti-HLA class I or anti-CD1 mAbs, inhibited the response of gamma delta T cells. Antibodies to gamma delta T cell receptor, CD2, CD3, or CD11a were also inhibitory, whereas antibodies to alpha beta T cell receptor, CD4, CD5, and CD8 had no effect. Although only 40-60% of freshly isolated gamma delta T cells expressed CD28, mAbs directed against CD28 or its ligand, CD80, were markedly inhibitory. Moreover, removal of CD28+ cells from the gamma delta T cell population nearly abrogated the response to DC. These results demonstrate that resting gamma delta T cells recognize and respond to MHC class II determinants on allogeneic DC in a manner that is highly dependent on the CD28 activation pathway as well as molecules such as CD2 Invest. 1995.95:296-303.)
Introduction y6 T cell receptor-bearing lymphocytes (yb T cells)' consti-
tute up to 10% of the peripheral blood T lymphocytes in man and are also found in substantial numbers within spleen, lymph nodes, and intestine ( 1, 2). They accumulate in the skin lesions of patients with leprosy or cutaneous leishmaniasis (3) and in the peripheral blood of patients with leishmania (4), malaria (5), Epstein Barr virus infection (6) , and HIV infections (7, 8 Receivedfor publication 6 June 1994 and in revisedform 23 September 1994.
1. Abbreviations used in this paper. DC, dendritic cells; DPBS, Dulbecco's calcium-and magnesium-free phosphate buffered saline; E+, E-rosette positive; y6 T cells, y6 T cell receptor bearing lymphocytes;
HS, human serum; TCR, T cell receptor.
recognize a variety of antigens including MHC class 1 (9-11), MHC class 11 (12, 13) , CD1 (14, 15) , and bacterial products such as mycobacterial proteins (3, 16) , tetanus toxin (17) , and Staphylococcus aureus enterotoxin-A (18) . Despite these observations, however, neither the physiological role of y6 T cells nor the cellular and molecular basis by which resting y6 T cells are activated is understood. In this study we sought to determine if fresh resting y6 T cells isolated from peripheral blood respond to allogeneic antigen-presenting cells and, if so, to assess the role in such responses of several cell surface molecules. The results indicate that dendritic cells (DC), but not monocytes, stimulate y6 T cells to proliferate and that accessory molecules such as CD2, CD1 la, and CD28 play critical roles in this process.
Methods mAb. mAb directed against CD2 (Leu Sb), CD3 (Leu 4, OKT3), CD4
(Leu 3a, OKT4), CD5 (Leu 1), CD8 (Leu 2a, OKT8), CD lla (LFAla), CD16 (Leu Ila, Leu llc), CDl9 (Leu 12), HLA-A,B,C (W6/ 32), HLA-DR (L243), and CD62L (Leu 8) were produced and purified in this laboratory. Anti-a/I T cell receptor (TCR) (BMA031) and antiy6 TCR (TCR6-1) mAb were purchased from T Cell Sciences, Inc., Cambridge, MA. mAb directed against CD56 (IOT56), CD72 (10B72), CDla (IOT6a), CDlb (IOT6b), and CDlc (IOT6c) were purchased from Amac, Inc., Westbrook, ME. (21) . Cells in the low density layer (DC enriched) were resuspended in 10% HS/RPMI and incubated in Teflon vessels for 1-2 h. This population was further depleted of contaminating monocytes by a solid phase absorption (panning) procedure using human IgG-coated petri dishes (22) . The unbound cells were then suspended in 2 ml of 5% HS/DPBS and layered over a second (14%) metrizamide gradient. To enrich DC to > 80% purity, a third (13%) metrizamide gradient was used.
Immunofluorescence analysis. Immunofluorescence analysis was performed as previously described (23 [16] [17] [18] [19] [20] h before harvesting. To assess the effects of anti-T cell mAb, T cells were incubated with the indicated mAb for 1 h at 4°C and, in addition, the 6-d cultures were performed in the presence of added mAb as indicated in the figure and table legends. Where indicated, mAb were added to the wells after varying periods of culture. Statistical analysis was performed by using the Student's t test.
Results
Immunofluorescence analysis of y6 T cells and antigen-presenting cells. As described in detail in Methods, y6 T cells were enriched from E+ cells by negative selection. More than 90% of these cells were y3 TCR+, CD4-, CD8-, while < 1% were a,/ TCR+ (n = 7). The phenotype of the major contaminating cells was CD2+, CD3-(< 5%, data not shown). As shown in Fig. 1 A, nearly all of the purified y6 T cells express CD2, CD5, and CD1 la molecules, and 40-60% also expressed CD28 (n = 6) by two-color analysis as shown in Fig. 1 B.
Populations enriched for either DC or monocytes were separated from PBMC on the basis of their differential densities, as described in Methods. DC-enriched populations, prepared from more than 30 individuals, stained brightly with anti-HLA-DR mAb, but stained weakly or not at all for CD3, CD14, CD19, or CD16 (Fig. 2 A) . In addition to HLA-DR, these cells also stained brightly with anti-CD80 (B7-1), anti-CD1c mAb, and HB-15 (not shown), but only weakly or not at all with mAb directed at CDla or CDlb (Fig. 2 B) . A small percentage of these cells stained with anti-CD72, consistent with slight B cell contamination. This cell population, which contained > 85% of cells with characteristic branched morphology, was used as DC for the assays described in this report. More than 95% of glass adherent cells obtained from the low density Percoll (Pharmacia LKB) fraction stained with both anti-CD14 and anti-HLA-DR mAb (Fig. 2 A) Fig. 3 A, y6 T cells responded to DC with a peak response on days 5-6 of culture. In contrast, purified monocytes failed to activate y6 T cells, regardless of the duration of culture (Fig. 3 A) . a,3
T cells, on the other hand, responded well to both DC and monocyte stimulator populations (Fig. 3 B) .
Response ofy6 and a/ T cells to graded numbers ofallogeneic DC or monocytes. As shown in Fig. 4 (Table I) .
Role of T cell surface molecules in the response of y6 T cells to DC. To explore the role of y6 T cell surface molecules in the response of these cells to allogeneic DC, cultures were performed in the presence of mAb directed at a variety of transmembrane molecules expressed on y6 T cells, af3 T cells or both. As shown in Fig. 5 , anti-CD3 and anti-y6 TCR mAb inhibited the response of y6 T cells, whereas anti-a/3 TCR, anti-CD4, and anti-CD8 mAb had no effect. On the other hand, the response of a,B CD4+ T cells was inhibited by anti-CD3, anti-a6 TCR, and anti-CD4 mAb, but not by anti-y6 TCR or anti-CD8 mAb. Table II shows that mAb to CD2, CD 11, and CD28 inhibited the response of both y6 and a/3 T cells. The results of three representative experiments demonstrated that anti-CD2 and anti-CDlla mAb inhibited the proliferative response of each T cell population to a similar extent, whereas anti-CD5 mAb had no effect on the response of either population. Although anti-CD28 mAb inhibited the response of both T cell populations, the inhibitory effect was substantially greater on y6 T cells (72-85%) than on ac3 T cells (39-45%). As shown in Fig. 6 , a mAb to B7-1 (CD80), which is a ligand of CD28, was less inhibitory of y6 and al3 T cell responses to DC than anti-CD28 mAb, but the effect of anti-B7-1 on the response of y6 T cells was greater than the effect of this mAb on the aB T cell response. The inhibitory effect of anti-CD80 is seen even at low concentrations (0.01 [ug/ml) of antibody. We believe that this effect may be explained by the low number of DC (104) per well such that even a small amount of antibody is sufficient to bind most of the CD80 molecules and produce an inhibitory effect. The higher number of CD28+ y6 T cells per well may explain why the inhibitory effect of anti-CD28 is reduced at low concentrations of antibody. In light of the potent inhibitory effect of anti-CD28 on the response of y6 T cells to allogeneic DC, further studies were undertaken to examine the basis of this effect. First, to determine when during the culture anti-CD28 exerted its effect, anti-CD28 mAb and a control mAb (CD62L) were added to cultures of y6 cells and DC at 0, 24, 48, 72, and 96 h. The results (Fig.  7) show that the inhibitory effect of anti-CD28 mAb was seen during the first 24 h of culture and disappeared thereafter for both y6 and af3 T cells. Finally, since 40-60% of y6 T cells (14, 15) . CDlb determinants have also been reported to serve as restriction elements in the proliferative and cytotoxic response of CD4-CD8-a/ T cells to microbial pathogens (27) . The DC used in our studies expressed CDla and CDlc, but not CDlb (Fig. 2 B) . Nonetheless, antibodies specific for these proteins did not inhibit the allogeneic response of y6 T cells, in contrast to the potent inhibitory effect of anti-HLA-DR (Table I Statistical analysis forA: anti-CD80 vs control (anti-CD62L), P < 0.05; anti-CD28 vs control, P < 0.01; anti-CD80 vs anti-CD28, P < 0.05. B: anti-CD80 vs control, P < 0.05; anti-CD28 vs control, P < 0.01; anti-CD80 vs anti-CD28, P < 0.05. *, anti-CD28; o, anti-CD80; A, anti-CD62L; o, no antibody. (29) . In association with immobilized anti-CD3 mAb, anti-CD5 mAb enhance IL-2 receptor expression and IL-2 production and initiate T cell proliferation (30) . However, while CD72 molecules are expressed by B cells, they are not expressed by most DC or monocytes (Fig. 2 B) , and anti-CD5 mAb had no effect on the response of y6 or af3 T cells to DC (Table II) .
These results suggests that CD5 molecules do not play a role in allogeneic mixed leukocyte reaction, a result consistent with other studies (28) . CD28 molecules are expressed on all or nearly all CD4+ T cells, the majority of CD8+ T cells (31) , and 40-60% of circulating y6 T cells (Fig. 1 B) (32). The interaction between CD28 and the B7-1 (CD80) molecule, which is expressed on differentiated DC as well as activated B cells (33) , y-interferon-activated monocytes (34) , and T cell clones (35) , results in augmentation of a,6 T cell activation initiated through the TCR (36), apparently as a consequence of the induction of IL-2 transcription and IL-2 receptor expression (37, 38 also twofold greater on ye than a/3 T cells (Fig. 6) . However, the potency of inhibition was less than that seen with anti-CD28. This result may be explained by the existence of a second ligand, B7-2, for CD28 (41) . Whereas B7-1 is expressed on activated but not resting antigen presenting cells, B7-2 is expressed on resting monocytes and DC as well as activated T, NK, and B cells. Anti-B7-2 mAb reportedly inhibits primary allogeneic mixed leukocyte reaction more efficiently than anti-B7-1, suggesting that the ligation of B7-2 and CD28 plays a significant role in the activation of resting a,6 T cells (41) . Our results suggest that the interactions between CD28 and its ligands on DC play an important role in the activation of resting ye T cells. The observation that the inhibitory effect of anti-CD28 mAb occurs during the first 24 h of culture (Fig. 7) is consistent with this interpretation.
In the current study we have attempted to address the cellular and molecular basis of ye T cell activation, in contrast to previous studies, which have focused on the functions of activated ye cells. For example, a variety of ye T cell lines and clones with cytotoxic activity have been generated from alloantigen stimulated cultures (9, 11, (42) (43) (44) , and in some examples the cytolytic activity has been restricted by MHC class 1 (9, 1 1 ) or II (44) determinants. Since noncytolytic, immunoregulatory effects have also been suggested to be mediated by ye T cells (45, 46) , ye5 T cells activated by allogeneic DC may be functionally heterogeneous. Regardless of their precise function(s), however, it is apparent that the cell-surface molecules described in this report are critical to the generation of effector cells that mediate these functions.
